Blog

M42 Announces Agreement to Acquire Stake in U.S. Rare Earth and Precious Metals Company

Companies to Leverage Innovative AI Platform to Further Define Major Shovel-Ready Metals Resource, Poised to Become One of World’s Largest Deposits

DALLAS, TX / ACCESS Newswire / October 22, 2025 / Messier 42 LLC (“M42”), a private leading global artificial intelligence technology and digital transformation company, announces that it has entered into an agreement to acquire a minority interest in a privately developed polymetallic metal resource company based in the Western U.S., specializing in precious, rare earth and critical metals. Initial production and positive cashflow is anticipated within 12 months.

This investment presents the opportunity to leverage M42’s successful Transformational AI platform to non-invasively locate and further define the resource company’s shovel-ready metals deposit. Both companies believe that the current NI43-101 Measured Resource Report, which is expected to be upgraded to a Probable Reserve Report based on retesting of assay results using more accurate methods, could reflect one of the world’s largest precious, critical and rare earth element deposits.

“As the global race to secure critical and rare earth elements intensifies, we are thrilled to have found a domestic partner with a world-class resource right here on American soil-where we can apply our AI platform to further define and advance the understanding of these strategic assets,” said Michael Sandoval, Chief Scientist of M42. “By reducing reliance on foreign supply chains, this initiative directly supports American national security while positioning the United States to remain competitive in the global race for technological and economic leadership in the 21st century.”

“This investment and partnership with M42 AI in our company strengthens U.S. capacity to secure critical minerals and rare earths-resources that are indispensable to defense systems, advanced semiconductors, renewable energy, and next-generation technologies.” said the spokesperson for the private resource company. “We look forward to working with the team at M42 AI to utilize their AI platform to advance our project.”

The private American company has been developing their world class mine site for over 6 years and is expected to start profitable production within 12 months. In addition to producing precious metals, it is expected to mine significant grades/amounts of key critical and rare earth metals, some of which are either not produced in the US or whose supplies are imported from politically unappealing parts of the world. The management team is comprised of experienced mining and corporate developmental individuals who have successfully built this unconventional project from its inception. Ultimately, the elements contained in this discovery, will enable innovation across critical sectors of the modern U.S. economy, including semiconductors, energy, robotics, defense, and aerospace.

The agreement is subject to certain conditions precedent and is expected to close before the end of the year.

About M42

M42 is a global leader in technology solutions and digital transformation, providing innovative services across various industries. As a syndicate leveraging AI for justice, truth and fairness, M42 combines deep expertise in artificial intelligence, cloud computing, and cybersecurity to drive growth and efficiency for its clients worldwide.

Forward Looking Statements

This document contains certain forward-looking statements within the meaning of Private Securities Litigation Reform Act of 1995. Forward-looking statements, including those related to the services provided by M42 and the private resource company and the consummation of the agreement, are statements that are based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond M42’s control. Except as required by law, M42 does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

M42 Contacts

Matthew Selinger, Senior Partner
Integrous Communications
Email: mselinger@integcom.us
Phone: 415-572-8152
Website: https://m42.com/

Visit us on social media:

Facebook = https://www.facebook.com/m42ai/
Instagram = https://www.instagram.com/m42_ai_/
X: https://x.com/M42_AI_

SOURCE: M42

View the original press release on ACCESS Newswire

October 23, 2025
Immortal Dragons Backs Unlimited Bio
Advancing Combinatorial Anti-Aging Therapies

SINGAPORE, SG / ACCESS Newswire / October 22, 2025 / Immortal Dragons, a $40 million longevity fund, announced its strategic investment in Unlimited Bio, a biotechnology company developing combinatorial therapies to address the multi-system nature of aging.

Combinatorial Therapeutic Strategy

Unlimited Bio’s platform integrates gene therapies, biologics, plasma-based interventions, cell therapies, and small-molecule programs targeting complementary mechanisms across organ systems. The company employs both repurposed approved compounds and proprietary candidates developed in-house.The approach is based on the premise that aging results from the concurrent failure of multiple interconnected biological systems, requiring a synergistic, large-scale combination of interventions acting across tissues and pathways.The initial gene therapy portfolio includes VEGF-A and Follistatin for vascular and muscular applications, and α-Klotho and BDNF for cognitive and neuroprotective applications VEGF-A gene therapy -an approved drug repurposed for vascular rejuvenation-has demonstrated up to ~7.5-fold (756%) increases in pain-free walking distance in patients with peripheral ischemia¹ and has been used in thousands of patients since 2011,² providing one of the more extensive post-marketing safety data sets among gene therapies in clinical use.³

“Aging is not a single pathway but a multi-system failure involving interdependent biological networks.” explained Ivan Morgunov, CEO of Unlimited Bio, “Our philosophy views this problem as an engineering challenge that demands an integrated, synergistic system-ultimately enabling safe combinations of dozens of interventions.”

Strategic Alignment

This investment advances Immortal Dragons’ engineering-centric approach to radical life extension. While the fund’s existing portfolio addresses organ failure through 3D biofabrication and artificial womb technology, Unlimited Bio’s platform targets the underlying mechanisms of biological aging-potentially extending functional lifespan of both natural and engineered tissues.

Further clinical validation will proceed through Special Economic Zones, specifically Prospera ZEDE, utilizing surrogate endpoints in healthy volunteers to enable cost-efficient trials meeting high safety standards.

Looking Ahead

Unlimited Bio’s near-term priority is the first-in-human clinical study combining two gene therapies in healthy participants – planned for late 2025 to early 2026, pending regulatory and ethics approvals. This study is described as the first clinical evaluation of a dual gene-therapy combination in healthy individuals and is aimed to serve as a proof-of-concept demonstrating the safety and synergistic rejuvenative potential of multi-gene interventions. Building on this foundation, the company will expand toward integrated therapeutic combinations across molecular, cellular, and systemic levels, creating a platform capable of continuously incorporating emerging longevity discoveries and optimizing intervention synergies over the next decade.

About Immortal Dragons

Immortal Dragons (https://www.id.life/) is a purpose-driven longevity fund headquartered in Singapore. The fund invests in cutting-edge, high-impact technologies and currently supports more than 15 portfolio companies. Beyond conventional investments, the fund advances longevity advocacy through book translation and publishing, translation of longevity leaders’ talks, hosting a leading Chinese-language longevity podcast, and providing sponsorships and grants to longevity initiatives and conferences.

For Press Inquiries:

Boyang Wang
Founder, Immortal Dragons
press@id.life

References
SOURCE: Immortal Dragons

View the original press release on ACCESS Newswire
October 23, 2025
Unusual Machines Appoints Jason Reels as Vice President of Supply Chain

Reels to strengthen operational execution and expand U.S.-based manufacturing capacity for defense and enterprise markets

ORLANDO, FLORIDA / ACCESS Newswire / October 20, 2025 / Unusual Machines (NYSE AMERICAN:UMAC), a leading provider of NDAA-compliant drone components, today announced the appointment of Jason Reels as Vice President of Supply Chain. Reels will report to Chief Operating Officer Andrew Camden and lead Unusual Machines’ global supply chain operations as the company expands production capacity across its U.S. facilities.

Reels will oversee inbound logistics, materials management, and fulfillment to improve speed, coordination, and throughput as the company scales motor and headset production to meet growing defense and enterprise demand.

“Operating a disciplined and efficient supply chain is the backbone of our ability to deliver,” said Andrew Camden, COO of Unusual Machines. “Jason’s experience leading complex logistics networks and scaling production across multiple regions will strengthen our execution as we continue expanding domestic manufacturing.”

Reels brings more than 15 years of experience across the automotive, manufacturing, and technology sectors, building multi-site supply chains in North America, Mexico, and Asia, and implementing ERP and warehouse systems aligned with NetSuite. His background supports Unusual Machines’ continued emphasis on reliability, compliance, and speed within its production network.

“We’re building for scale in a way that keeps control and quality front and center,” said Jason Reels. “I’m focused on building the systems and teams that keep production moving at the speed our customers have come to expect from Unusual Machines.”

About Unusual Machines

Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot ecommerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032.

For more information, please visit www.unusualmachines.com.

Investor Contact

CS Investor Relations
investors@unusualmachines.com

Media Contact

media@unusualmachines.com

SOURCE: Unusual Machines, Inc.

View the original press release on ACCESS Newswire

October 23, 2025
WhiteSands Releases New Guide Answering: How To Recognize the Early Signs of Vicodin Addiction

CLEARWATER, FL – October 17, 2025 – PRESSADVANTAGE –

WhiteSands Alcohol & Drug Rehab Clearwater has released a new online resource titled “Understanding the Signs of Vicodin Addiction“, available on their website. The article offers families and patients practical insight into identifying early warning signs of opioid misuse, the risks associated with Vicodin, and the importance of timely access to supervised withdrawal care.

The publication highlights that Vicodin, a prescription medication often used for pain relief, carries a high potential for dependence when misused. Many people may not recognize the gradual shift from prescribed use to abuse until physical and psychological symptoms are already present. The article outlines key indicators such as behavioral changes, mood swings, and withdrawal effects as important signals that medical attention is necessary. By presenting this information in clear terms, WhiteSands aims to shorten the time between the onset of symptoms and seeking treatment.

The resource underscores that opioid addiction is a medical condition, not a personal weakness. Patients who attempt to stop using Vicodin without clinical guidance often encounter intense withdrawal symptoms, including nausea, muscle pain, anxiety, and insomnia. These symptoms can quickly lead to relapse if detox is attempted outside a supervised setting. Drawing on findings from the Substance Abuse and Mental Health Services Administration (SAMHSA), the article explains that medically supported detox programs improve patient safety and increase the likelihood of successful recovery.

WhiteSands Clearwater emphasizes the importance of supervised detoxification as the foundation for effective addiction treatment. The center provides 24/7 monitoring in medically supported environments, along with access to medication-assisted protocols that ease discomfort and reduce risks during withdrawal. Detox alone, however, is not sufficient for long-term recovery. Once patients stabilize, they are encouraged to transition into comprehensive care programs that address the psychological and behavioral drivers of addiction through inpatient or outpatient therapy, relapse prevention strategies, and long-term recovery planning.

The article also explains the importance of integrating detox with evidence-based counseling. Detox clears the body of substances, but therapy addresses the underlying issues that fuel addiction. Combining these approaches ensures patients begin recovery with both physical stability and a plan for emotional and mental health support. Research from the National Institute on Drug Abuse (NIDA) is cited, noting that treatment outcomes are stronger when detoxification is followed by structured therapy and ongoing support services.

Financial accessibility is another factor addressed in the resource. The article highlights the value of treatment programs that strike a balance between affordability and clinical quality, noting that cost concerns often deter families from seeking help. By encouraging patients and their loved ones to explore programs that provide both safety and cost-effective care, WhiteSands aims to reduce the barriers that prevent people from pursuing treatment.

Local context is acknowledged throughout the publication, with attention given to the needs of Clearwater residents and the surrounding areas. Whether in coastal neighborhoods like Clearwater Beach or smaller nearby communities, the challenges of opioid misuse remain consistent: families often struggle to recognize when prescription use has become dependency, and patients may delay care until the addiction is advanced. The resource seeks to address this gap in awareness by offering guidance that is both medically accurate and accessible to all patients.

The article concludes by stressing the urgency of early intervention. Delays in addressing Vicodin misuse can lead to worsening dependence, health complications, and increased risk of overdose. By making information available online, WhiteSands aims to reach families at the critical point when questions first arise about whether a loved one may be struggling with opioid misuse.

For people searching for “drug rehab near me” or “medication-assisted detox in Clearwater,” this resource provides clear, evidence-based information rather than promotional promises. It is designed to help families make informed decisions, emphasizing that recovery begins with recognizing the signs and taking action promptly.

With the release of Understanding the Signs of Vicodin Addiction, WhiteSands Alcohol & Drug Rehab reinforces its role as both a treatment provider and an educational resource. By focusing on the warning signs of opioid misuse and the importance of supervised detox, the center continues its mission to support patients and families with compassion, clinical expertise, and a commitment to long-term recovery.

###

For more information about WhiteSands Alcohol & Drug Rehab Clearwater, contact the company here:

WhiteSands Alcohol & Drug Rehab Clearwater
Ryan Monesson
(727) 270-9970
rmonesson@wstreatment.com
1932 Drew St, Clearwater, FL 33765

October 23, 2025
Ketamine Therapy for Anxiety and PTSD Highlighted in Resource from Moment of Clarity

Huntington Beach, California – October 17, 2025 – PRESSADVANTAGE –

Moment of Clarity has published a new resource titled “Using Ketamine for Anxiety and PTSD Treatment“, now available on their website. The article examines how ketamine therapy may support patients living with anxiety disorders and post-traumatic stress disorder (PTSD), particularly those who have not found sufficient relief through traditional treatments. The resource aims to provide patients, families, and communities with a clear understanding of where ketamine fits within modern mental health care.

Anxiety and PTSD are among the most common mental health challenges, often accompanied by symptoms that disrupt sleep, relationships, and daily functioning. Standard therapies such as medication and counseling remain effective for many, but a significant number of patients experience treatment-resistant symptoms. The publication explains how ketamine, administered in controlled clinical settings, interacts with brain receptors linked to mood regulation and may provide rapid symptom relief. Unlike conventional antidepressants that may take weeks to show benefits, ketamine has demonstrated a faster onset in certain patients.

Research supports these observations. Studies published in JAMA Psychiatry (2019) and clinical reviews from the National Institutes of Health indicate that ketamine can reduce symptoms of depression and trauma-related conditions in some individuals who did not respond to other treatments. However, the article makes clear that while ketamine is FDA-approved as an anesthetic and esketamine (Spravato) is FDA-approved for treatment-resistant depression, the use of ketamine for anxiety and PTSD remains off-label and should only be provided under careful medical supervision.

For patients in Huntington Beach, California, the resource highlights how ketamine therapy may complement existing services such as group therapy, family counseling, and psychiatric evaluations. By reducing the intensity of acute symptoms, ketamine may allow patients to engage more effectively in talk therapy and skill-building interventions. The article emphasizes that ketamine is not a replacement for these services, but a tool that can strengthen their impact.

The publication also addresses safety. Administered in licensed medical environments, ketamine therapy is closely monitored to ensure patient well-being. Common side effects, such as dizziness or mild dissociation, are typically temporary and resolve on their own. Medical supervision ensures that dosing is carefully controlled and that patients receive support throughout each session.

Another focus is the importance of trauma-informed care. Many patients struggling with PTSD also live with co-occurring conditions such as depression or substance use disorders. The article notes that ketamine therapy is most effective when integrated into comprehensive care programs that may also include cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and medication management. This integrative approach reflects a commitment to addressing both the biological and psychological aspects of recovery.

Moment of Clarity’s resource also acknowledges the stigma that can surround advanced therapies. Some patients hesitate to explore newer treatments due to fear of judgment or misconceptions about them. By providing evidence-informed explanations of ketamine’s role, the publication seeks to normalize the use of innovative therapies alongside established methods, encouraging earlier access to care.

Continuity of care is another central theme. While ketamine therapy may provide rapid relief, the resource emphasizes that lasting recovery depends on ongoing therapeutic engagement. Patients may begin with ketamine sessions but require continued counseling, family therapy, and psychiatric evaluations to build resilience and maintain progress over time.

By publishing Using Ketamine for Anxiety and PTSD Treatment, Moment of Clarity reinforces its role as a trusted provider of patient education. The article explains how ketamine therapy works, clarifies its regulatory status, reviews emerging research, and highlights its potential integration into broader treatment plans.

For individuals in Huntington Beach and the surrounding area seeking reliable information on advanced mental health options, this resource offers balanced, research-based guidance. By combining education with clinical expertise, Moment of Clarity in Huntington Beach helps patients and families explore innovative recovery pathways while maintaining confidence in the safety and effectiveness of their care.

###

For more information about Moment of Clarity Huntington Beach, contact the company here:

Moment of Clarity Huntington Beach
Marie Mello
(949) 403-6740
marie@momentofclarity.com

October 23, 2025
Ginza Diamond Shiraishi Hong Kong Highlights the Craftsmanship and Symbolism Behind Diamond Rings

Causeway Bay, HK – October 17, 2025 – PRESSADVANTAGE –

Ginza Diamond Shiraishi Hong Kong has issued a detailed overview exploring the evolving artistry, craftsmanship, and symbolism behind its collection of 鑽石戒指 (diamond rings). The announcement aims to highlight the methods and philosophy that guide the brand’s approach to ring design and production, reflecting its continuing role in Hong Kong’s fine jewelry landscape.

The brand’s new initiative focuses on documenting and communicating the processes that define the structure and aesthetic of a modern wedding ring. The study includes information about sourcing, design methodology, precision cutting, and the cultural context of diamond rings creation. According to the company’s design division, the purpose is to help customers, collectors, and industry observers understand the balance between material science and emotional symbolism that each ring represents.

Each diamond ring produced under the Ginza Diamond Shiraishi name is based on an in-house design language emphasizing precision geometry and light performance. The diamond setting is adjusted to achieve optimal brilliance under natural and artificial light conditions, while maintaining minimal interference with the stone’s inherent symmetry. This design logic is the result of iterative collaboration between gemologists, designers, and metal artisans who evaluate how light travels within and beyond the stone.

The company’s production team has also provided details about its quality management framework. Stones undergo multiple inspection stages to confirm cut accuracy, clarity consistency, and color calibration. In recent years, attention has also been directed to traceability—ensuring that each diamond can be traced to a verified and ethically responsible source. These measures align with global standards for responsible sourcing and are monitored through a network of certified suppliers and independent evaluators.

The metals used in the brand’s wedding ring settings are selected based on durability and compatibility with the optical behavior of the diamonds. Alloys are adjusted to achieve specific tonal warmth—yellow gold, rose gold, and platinum are formulated with slight compositional variations to harmonize with the brilliance and color of the mounted stone. This technical approach aims to preserve long-term luster and minimize surface wear, an aspect regarded as essential in jewelry that represents permanence.

From a design perspective, Ginza Diamond Shiraishi Hong Kong continues to employ both traditional and contemporary design processes. Initial sketches are created by hand, maintaining an artistic interpretation of each collection’s theme. These are followed by digital modeling stages where engineers simulate the balance, weight, and comfort of the ring. The result combines aesthetic fluidity with structural stability, ensuring that every diamond ring performs both as a symbol and as a precise engineered object.

Industry observers have noted that demand for 鑽石戒指 (diamond rings) continues to evolve beyond simple aesthetic value. The modern consumer increasingly seeks transparency in sourcing, personalization options, and lasting durability. Ginza Diamond Shiraishi Hong Kong’s focus on educational initiatives and process documentation responds to these shifts by providing verifiable insight into the material and ethical standards of its products.

The announcement also covers recent research by the company’s gemological division, which investigates how microvariations in cut proportion influence light return and dispersion. Data from these studies have been applied to optimize the angular design of selected ring settings, improving perceived brightness and color fire. According to the internal report, even minor adjustments of less than one degree in pavilion angle or crown height can meaningfully alter light diffusion within a diamond ring, reinforcing the brand’s emphasis on scientific precision in jewelry design.

The firm’s workshop continues to function as both a production facility and a training environment. Artisans are instructed in metal shaping, micro-setting, and finishing techniques that require precision to the tenth of a millimeter. Through this dual-purpose structure, Ginza Diamond Shiraishi maintains consistency across its output while passing technical knowledge to emerging craftsmen. The company believes this balance between tradition and innovation is essential for sustaining quality standards in fine jewelry manufacturing.

To further strengthen customer understanding, the brand has also enhanced its consultation process. Prospective clients can now access design demonstrations showing how minor changes in diamond size, band curvature, or setting height affect both visual and ergonomic qualities. While the initiative is not promotional in nature, it contributes to broader literacy around jewelry design and helps customers make informed decisions based on measurable factors rather than aesthetic preference alone.

The report includes commentary from independent jewelry analysts who observe that 鑽石戒指 (diamond rings) remain among the most technically sophisticated items in luxury design due to their optical complexity and emotional significance. They note that brands capable of integrating craftsmanship with educational transparency are increasingly regarded as leaders in the field. Ginza Diamond Shiraishi’s initiative reflects this perspective by combining detailed production disclosure with a commitment to preserving design integrity.

In addition to physical craftsmanship, the company has introduced digital archiving methods for each ring’s lifecycle documentation. This includes design specifications, sourcing certificates, and quality assurance records. Stored securely, this data allows long-term verification of each piece’s authenticity and material origin. Such documentation practices correspond with industry trends emphasizing digital provenance and responsible ownership verification.

The new documentation and communication measures do not alter the company’s product range but instead provide an updated framework for understanding the diamond ring as both an artistic and technical object. The approach aligns with a broader movement within the jewelry sector toward accountability, traceability, and respect for traditional craftsmanship.

Ginza Diamond Shiraishi Hong Kong’s statement concludes by reiterating its position that a wedding ring represents not only craftsmanship but also shared meaning. Through the integration of design discipline, material science, and ethical production, the company aims to preserve the essence of the diamond rings as a lasting symbol of connection while promoting deeper awareness of the processes that give it form.

The information outlined in the announcement reflects the brand’s ongoing dedication to combining artistry with responsibility—core attributes that define its contribution to the international jewelry community. The initiative also illustrates how precision in production and clarity in communication can coexist to maintain public trust in the value and authenticity of the diamond ring tradition.

For more information, please read:

https://pressadvantage.com/story/83942-ginza-diamond-shiraishi-hong-kong-highlights-commitment-to-engagement-ring-craft-and-consumer-trends

###

For more information about Ginza Diamond Shiraishi Causeway Bay 銀座白石銅鑼灣, contact the company here:

Ginza Diamond Shiraishi Causeway Bay 銀座白石銅鑼灣
Mr. Shiraishi
(852) 2787 0606
admin@diamond-shiraishi.hk
Shop G29-30, Fashion Walk, 11-19 Great George Street, Causeway Bay, Hong Kong

October 23, 2025
GenHealth.ai and Guidehealth Achieve Up to 60% Reduction in Utilization Management Workload Through AI-Native Platform
GenHealth.ai and Guidehealth achieved up to a 60% reduction in Utilization Management workload using GenHealth’s AI-native platform, leading to $1.2M in annual savings. The system automates clinical data extraction and policy evaluations, improving efficiency, compliance, and decision consistency above 90%.

BOSTON, MA / ACCESS Newswire / October 17, 2025 / GenHealth.ai, a leader in AI-native healthcare automation, today announced the successful deployment of its AI-driven Utilization Management (UM) and Prior Authorization (PA) platform with Guidehealth, an At Risk Managed Services Organization (MSO). The collaboration resulted in up to 60% reduction in UM workload across multiple care settings, significantly improving efficiency, compliance, and an estimated annual cost savings of $1.2m.

GenHealth.ai x Guidehealth

GenHealth’s AI-native UM platform integrates seamlessly with existing medical guidelines, administrative policies, and provider portals to automate data intake, escalation logic, and decision recommendations-without disrupting existing workflows. During the initial pilot nearly thousands of cases were processed in 4 months before further expansion.

“Healthcare utilization management has long been constrained by manual review and fragmented workflows,” said Ethan Siegel, Co-Founder of GenHealth.ai. “Our work with Guidehealth proves that AI can dramatically streamline these processes while maintaining trust, transparency, and full regulatory compliance.”

Transforming Utilization Management with Human-Centered AI

GenHealth’s solution leverages Large Language Models (LLMs) and predictive algorithms to interpret and apply complex medical and administrative policies. The system automatically extracts, summarizes, and structures clinical data from PDFs, faxes, and call center transcripts-reducing RN manual review time by an average of one hour per Skilled Nursing Facility (SNF) case and accelerating medical policy evaluations to under ten minutes per case.

Each AI-generated recommendation includes detailed citations for every decision step, ensuring complete auditability and compliance with CMS, NCQA, and state-level regulations.

Key Results and Impact
- Up to 60% workload reduction across utilization management teams
- 90%+ consistency in decision-making, improving fairness and reducing provider abrasion
- ~$1.2 million projected annual cost savings across multiple IPAs
- Full compliance and transparency in AI-assisted medical decision-making
“These results are just the beginning,” said Ricky Sahu, CEO and Co-Founder of GenHealth.ai. “As we expand our UM automation capabilities into behavioral health, concurrent review, and SUD services, the impact on efficiency and patient access to care will multiply.”

Download the full case study to learn more about the implementation details and outcomes here.

About GenHealth.ai

GenHealth.ai builds AI-native infrastructure for healthcare organizations, empowering payers and providers to automate utilization management, prior authorization, and clinical review processes. By combining large medical models, predictive analytics, and human-centered design, GenHealth enables clients to streamline operations, ensure compliance, and improve patient outcomes.

For more information, visit www.genhealth.ai.

About Guidehealth

Guidehealth is an At Risk Managed Services Organization (MSO) that partners with Independent Physician Associations (IPAs) and provider networks to improve care quality and operational efficiency. The company specializes in value-based care programs, utilization management, and provider engagement strategies. Guidehealth leverages technology and data-driven insights to optimize patient outcomes while supporting clinicians in delivering coordinated, high-quality care

Contact Information

Mike Maseda
Head of Sales & Operations
marketing@genhealth.ai

SOURCE: Genhealth AI

View the original press release on ACCESS Newswire
October 23, 2025
XCF Global Regains Compliance with Nasdaq Listing Requirements

HOUSTON, TEXAS / ACCESS Newswire / October 17, 2025 / XCF Global, Inc. (“XCF”) (Nasdaq:SAFX), a key player in decarbonizing the aviation industry through Sustainable Aviation Fuel (“SAF”), today announces that it has filed its Quarterly Report on Form 10-Q for the period ended June 30, 2025, with the U.S. Securities and Exchange Commission (“SEC”).

As a result of the filing, the company has regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the SEC.

The Form 10-Q is available on the SEC’s website at www.sec.gov.

About XCF Global, Inc.

XCF Global, Inc. is a pioneering sustainable aviation fuel company dedicated to accelerating the aviation industry’s transition to net-zero emissions. XCF is developing and operating state-of-the-art clean fuel SAF production facilities engineered to the highest levels of compliance, reliability, and quality. The company is actively building partnerships across the energy and transportation sectors to accelerate the adoption of SAF on a global scale. XCF is listed on the Nasdaq Capital Market and trades under the ticker, SAFX. Current outstanding shares: ~159.2 million; <20% free float (as of October 17, 2025).

To learn more, visit www.xcf.global.

Contacts

XCF Global:
C/O Camarco
XCFGlobal@camarco.co.uk

Media:

Camarco
Andrew Archer | Rosie Driscoll | Violet Wilson
XCFGlobal@camarco.co.uk

Forward Looking Statements

This Press Release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, statements regarding XCF Global’s expectations with respect to future performance and anticipated financial impacts of the recently completed business combination with Focus Impact BH3 Acquisition Company (the “Business Combination”), estimates and forecasts of other financial and performance metrics, and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by XCF Global and its management, are inherently uncertain and subject to material change. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in domestic and foreign business, market, financial, political, and legal conditions; (2) unexpected increases in XCF Global’s expenses, including manufacturing and operating expenses and interest expenses, as a result of potential inflationary pressures, changes in interest rates and other factors; (3) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to XCF Global’s offtake arrangements; (4) the outcome of any legal proceedings that may be instituted against the parties to the Business Combination or others; (5) XCF Global’s ability to regain compliance with Nasdaq’s continued listing standards and thereafter continue to meet Nasdaq’s continued listing standards; (6) XCF Global’s ability to integrate the operations of New Rise and implement its business plan on its anticipated timeline; (7) XCF Global’s ability to raise financing to fund its operations and business plan and the terms of any such financing; (8) the New Rise Reno production facility’s ability to produce the anticipated quantities of SAF without interruption or material changes to the SAF production process; (9) the New Rise Reno production facility’s ability to produce renewable diesel in commercial quantities without interruption during the ongoing SAF ramp-up process; (10) XCF Global’s ability to resolve current disputes between its New Rise subsidiary and its landlord with respect to the ground lease for the New Rise Reno facility; (11) XCF Global’s ability to resolve current disputes between its New Rise subsidiary and its primary lender with respect to loans outstanding that were used in the development of the New Rise Reno facility; (12) payment of fees, expenses and other costs related to the completion of the Business Combination and the New Rise acquisitions; (13) the risk of disruption to the current plans and operations of XCF Global as a result of the consummation of the Business Combination; (14) XCF Global’s ability to recognize the anticipated benefits of the Business Combination and the New Rise acquisitions, which may be affected by, among other things, competition, the ability of XCF Global to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (15) changes in applicable laws or regulations; (16) risks related to extensive regulation, compliance obligations and rigorous enforcement by federal, state, and non-U.S. governmental authorities; (17) the possibility that XCF Global may be adversely affected by other economic, business, and/or competitive factors; (18) the availability of tax credits and other federal, state or local government support; (19) risks relating to XCF Global’s and New Rise’s key intellectual property rights, including the possible infringement of their intellectual property rights by third parties; (20) the risk that XCF Global’s reporting and compliance obligations as a publicly-traded company divert management resources from business operations; (21) the effects of increased costs associated with operating as a public company; and (22) various factors beyond management’s control, including general economic conditions and other risks, uncertainties and factors set forth in XCF Global’s filings with the Securities and Exchange Commission (“SEC”), including the final proxy statement/prospectus relating to the Business Combination filed with the SEC on February 6, 2025, this Press Release and other filings XCF Global made or will make with the SEC in the future. If any of the risks actually occur, either alone or in combination with other events or circumstances, or XCF Global’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that XCF Global does not presently know or that it currently believes are not material that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect XCF Global’s expectations, plans or forecasts of future events and views as of the date of this Press Release. These forward-looking statements should not be relied upon as representing XCF Global’s assessments as of any date subsequent to the date of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. While XCF Global may elect to update these forward-looking statements at some point in the future, XCF Global specifically disclaims any obligation to do so.

SOURCE: XCF Global, Inc.

View the original press release on ACCESS Newswire

October 23, 2025
Research Defense Examines Violence, Illiteracy, Non-Active Fathers, and Low Self-Esteem Among Males
Evidence-Based Research Presents Household-First Strategy for Community Transformation
Oct. 22, 2025 / PRZen / ARLINGTON, Texas — Bruce C. Carter will defend his doctoral dissertation on Sunday, November 16, 2025, at the University of Texas at Arlington, presenting years of rigorous research on reducing violence, engaging fathers, and strengthening households across America’s most challenged communities.

The public dissertation defense, titled “WHO REALLY CARES? Examining Violence, Illiteracy, Non-Active Fathers, and Low Self-Esteem as Agents of Constructive Genocide Among Black Males in America Ages 12-26,” offers evidence-based findings that challenge conventional approaches to violence prevention and community development.

FOUR-PILLAR STRATEGY

Carter’s research introduces a household-first approach using four co-equal interventions:
- Solid Foundation Certification (SFC) – Personal development before technical skills, building self-worth and financial literacy
- Standing on Business (SoB) – Economic empowerment through entrepreneurship and job placement pathways
- Eatz & Learn (E&L) – Household nutrition and education integration through family meal routines
- Becoming The Best Dad (BTBD) – Structured father engagement, co-parenting skills, and school presence
The research demonstrates that households participating in multiple pillars experience greater reductions in violence involvement compared to traditional single-intervention programs, providing evidence for an integrated, sustainable approach to community transformation.

BRIDGING RESEARCH AND IMPLEMENTATION

“Community programs fold when funding ends,” Carter explains. “Twenty years of observation confirms this pattern. This research validates what practitioners know – sustainable change requires addressing root causes simultaneously across multiple domains.”

Carter brings a unique perspective as both researcher and practitioner, having influenced over 500,000 young people through community-based interventions before pursuing doctoral research. His work was conducted along the I-94 corridor in Kenosha, Racine, and Milwaukee, Wisconsin – communities deeply affected by violence, educational disparities, and family fragmentation.

RESEARCH SIGNIFICANCE

The dissertation addresses critical gaps in violence prevention research:
- Household-Level Analysis: Treats families as the unit of change
- Multi-Component Synergy: Tests whether simultaneous interventions produce compounded effects
- Father Engagement Focus: Examines how structured father presence reduces violence risk
- Economic Pathways: Links legal earning opportunities to incident reduction
- Implementation Science: Provides replicable models for community adoption
Key findings include measurable improvements in school attendance, literacy outcomes, household food security, father-school engagement, and reductions in violence incident involvement among participating households.

POLICY IMPLICATIONS

The research has significant implications for federal and state spending accountability, household-first public safety strategies, father engagement as educational intervention, entrepreneurship pathways as violence prevention, and evidence-based models for engaging non-residential and justice-involved fathers.

EVENT DETAILS

What: Public Doctoral Dissertation Defense
Title: “WHO REALLY CARES? Examining Violence, Illiteracy, Non-Active Fathers, and Low Self-Esteem as Agents of Constructive Genocide Among Black Males in America Ages 12-26”
Who: Bruce C. Carter, Doctoral Candidate
When: Sunday, November 16, 2025, at 1:00 PM CST
Where: University of Texas at Arlington – Lone Star Auditorium, 300 W. First St, Arlington, TX 76010
Format: In-person attendance only
Cost: No admission fee. RSVP required
RSVP: https://carterempowers.com/events

The defense is relevant for community leaders, policy makers, violence prevention professionals, educators, nonprofit directors, fatherhood program staff, researchers, and concerned citizens. Following the defense, Carter will participate in a public question-and-answer session.

ABOUT BRUCE C. CARTER

Bruce C. Carter is an entrepreneur, business coach, and solutionist with over 20 years of experience developing sustainable community solutions. As founder of Carter Empowers and creator of the Empowerment Network, he has established replicable models for community-driven transformation.

MEDIA OPPORTUNITIES

Bruce C. Carter is available for interviews before and after the dissertation defense. He can discuss research methodology and findings, the four-pillar household-first strategy, violence prevention policy and practice, father engagement, economic pathways, and implementation strategies for communities.

Media Kit: carterempowers.com/press

Media Contact
Bruce Carter
Carter Empowers
855-252-7823
outreach@carterempowers.com

Press Release Distributed by PRLog

Source: Carter Empowers

Follow the full story here: https://przen.com/pr/33596378
October 23, 2025
Local College Student Launches “Cleopatra” App to Make Cleaning Easy for Mercer County Residents

20-year-old founder brings stress-free, vetted cleaning to Mercer County, including Princeton, Hamilton, Lawrenceville & West Windsor.

Oct. 21, 2025 / PRZen / PRINCETON, N.J. — While most 20-year-olds are buried in textbooks and caffeine, Alexander Varughese was building something cleaner. Literally.

Introducing Cleopatra, a beautifully designed app that makes booking a trusted cleaner as effortless as ordering takeout. No quotes. No calls. No surprises. Just a spotless home, handled start to finish with precision and care.

Cleopatra officially launched on August 25, 2025 in Mercer County. Early users describe the app as fast, reliable, and refreshingly personal, a simple way to keep homes spotless without the stress of traditional scheduling.

“I kept hearing how stressful it was for people to find someone they could trust,” said Varughese. “With Cleopatra, I wanted to build something that feels human, fast, and dependable, the kind of experience I’d want for my own home.”

Cleopatra replaces phone tag and sketchy pricing with a few simple taps. Users can book in minutes, get matched with a vetted local cleaner, and pay securely in the app. Every CleoCrew member is background-checked, verified, and continuously reviewed using AI-powered quality systems to ensure consistent results.

The response has been overwhelmingly positive. “We’ve been doing cleanings all over Mercer County and are loved by our clients,” said Varughese. “Seeing how much relief it brings to both families and our CleoCrew members has been the most rewarding part.”

Here’s how it works: tell Cleopatra about your space and needs, get matched with a verified CleoCrew member nearby, and relax while your home shines.

From one-time deep cleans to weekly refreshes, Cleopatra brings modern convenience to an age-old chore. The app offers real-time updates, transparent pricing, and recurring scheduling so your home stays spotless without the stress.

Cleopatra proudly serves Princeton, Hamilton, Lawrenceville, West Windsor, East Windsor, Robbinsville, Ewing, Trenton, Hightstown, and Pennington, bringing modern cleaning to every corner of Mercer County.

“Inviting someone into your home is personal,” Varughese added. “That’s why safety, reliability, and respect come first. You tap, we clean, and you always know who’s coming.”

Beyond clients, Cleopatra also focuses on empowering cleaners. While many on-demand platforms keep most of the earnings, Cleopatra gives the majority directly to its cleaners. Each CleoCrew member earns fair pay, receives consistent work through the platform, and gets access to training and safety resources to help them grow.

Cleopatra. From mess to majesty, one clean at a time.
Or as Varughese puts it, smiling, “She came. She saw. She sanitized.”

Now available on iOS and Android for residents across Mercer County. Download at trycleopatra.com

Contact:
Cleopatra Inc.
Email: support@trycleopatra.com
Website: trycleopatra.com
Phone: (888) 265-4440
Location: Mercer County, NJ

Contact
Cleopatra
(888) 265-4440
support@trycleopatra.com

Press Release Distributed by PRLog

Source: Cleopatra, Inc.

Follow the full story here: https://przen.com/pr/33596276

October 23, 2025